Spots Global Cancer Trial Database for human epidermal growth factor receptor 2 positive breast cancer
Every month we try and update this database with for human epidermal growth factor receptor 2 positive breast cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer | NCT04739761 | Breast Cancer | Trastuzumab Der... | 18 Years - 130 Years | AstraZeneca | |
A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer | NCT04739761 | Breast Cancer | Trastuzumab Der... | 18 Years - 130 Years | AstraZeneca |